U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387094) titled 'A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy' on Jan. 28.

Brief Summary: The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP

Study Start Date: March 03

Study Type: INTERVENTIONAL

Condition: OSA - Obstructive Sleep Apnea Obesity

Intervention: DRUG: XW003 injection

subcutaneous injection

DRUG: placebo with matching volume

subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.

Disclaimer: Curated by HT Syndication....